Vaccine News and Research

Latest Vaccine News and Research

Swine flu preoccupies world health leaders

It is expected that the upcoming World Health Organisation's (WHO) annual assembly will be dominated this year by the emergence and spread of the new influenza virus H1N1 (swine flu).

14 May 2009

Herpes drug Acyclovir does not reduce risk of HIV transmission, does slow HIV progression, study says

The drug acyclovir, which suppresses herpes simplex virus-2, does not reduce the risk of HIV transmission when taken by HIV-positive people who also have herpes, according to a study conducted by researchers at the University of Washington, United Press International reports.

14 May 2009

Many Americans support increased domestic funding to address HIV/AIDS, report says

Many Americans support increased funding to address HIV/AIDS in the U.S. according to a report released Wednesday for the National AIDS Coordinating Committee with support from the MAC AIDS Fund, Reuters Health reports.

14 May 2009

HIV drugs from plants

A research team at Örebro University in Sweden has succeeded in changing the genes in plants so they can function as a vaccine against HIV.

14 May 2009

Cimzia approved in U.S. for rheumatoid arthritis

UCB announced today that the U.S. Food and Drug Administration (FDA) approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

13 May 2009

Baylor Research Institute receives multi-million dollar grant to develop flu vaccine

Scientists at Baylor Institute for Immunology Research (BIIR) in Dallas, part of Baylor Research Institute (BRI) and the Baylor Health Care System, announced today that they received a renewal of a multi-million dollar grant from the National Institutes of Health (NIH) to design new vaccines to prevent influenza - including swine flu (H1N1).

13 May 2009

New insights into immune exhaustion

A main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out.

13 May 2009

Influenza pandemic planning needed to ensure that pregnant women and newborns receive priority treatment

Pregnant women and newborns are at greatest risk in a flu epidemic, but more planning must be done to ensure that they receive priority treatment should an outbreak occur, according to a University of Pittsburgh Medical Center (UPMC) and University of Pittsburgh study.

13 May 2009

Alzheimer's vaccine slows progression of inclusion body myositis

A potential vaccine for Alzheimer's disease also has been shown in mice to slow the weakening of muscles associated with inclusion body myositis, a disorder that affects the elderly.

13 May 2009

Break through in the treatment of bacterial meningitis

It can take just hours after the symptoms appear for someone to die from bacterial meningitis. Now, after years of research, experts at The University of Nottingham have finally discovered how the deadly meningococcal bacteria is able to break through the body's natural defence mechanism and attack the brain.

13 May 2009

Research looks at advanced radiation therapy technique for pancreatic cancer

According to the American Cancer Society, pancreatic cancer is the fourth leading cancer killer in the country, with more than 42,000 new cases expected to be diagnosed this year and more than 35,000 deaths. In New Jersey alone, 1,000 deaths are estimated from the disease, which only has a five-year, five-percent survival rate.

12 May 2009

Simple interventions could contain flu spread – focus on children

Although many have touted strategies from travel avoidance to Tamiflu to halt the spread of H1N1 flu or swine flu, a large body of evidence from the Cochrane Library suggests that concentrating on children's hygiene might be the best way to reduce the spread of respiratory illnesses.

12 May 2009

A potentially better way to make flu virus vaccines

A team of Princeton University scientists may have found a better way to make a vaccine against the flu virus.

12 May 2009

CDC to review vaccine policies; immigrant, women's rights advocates anticipating repeal of HPV vaccine requirement

A coalition of more than 100 groups representing women, immigrants, and public health and reproductive rights advocates are hoping CDC will repeal its rule requiring female immigrants seeking U.S. citizenship to receive the human papillomavirus vaccine Gardasil, the AP/Newark Star-Ledger reports (Garay, AP/Newark Star-Ledger, 5/7).

12 May 2009

Researchers screen the smallpox proteome

University of Florida researchers have learned more about how smallpox conducts its deadly business - discoveries that may reveal as much about the human immune system as they do about one of the world's most feared pathogens.

12 May 2009

Money from Bill and Melinda Gates will help beat Dengue fever in Australia

The University of Queensland (UQ) has won a grant of $100,000 grant from the Bill and Melinda Gates Foundation to fight dengue and other mosquito-borne diseases.

11 May 2009

Australian scientists win funds for new research

One bold idea - that's all it takes - such is the creed of a bold initiative fostered by the Bill & Melinda Gates Foundation and once again Bill Gates is putting his hand in his pocket for the good of mankind.

11 May 2009

$10.4 billion increase in NIH funding could increase HIV/AIDS research

Bloomberg on Wednesday examined how the $10.4 billion increase in NIH funding that is part of the $787 billion economic stimulus plan could boost funding for HIV/AIDS research.

7 May 2009

Study reveals current multi-component vaccines may need reworking

Current strategies for designing vaccines against HIV and cancers, for instance, may enable some components in multi-component vaccines to cancel the effect of others on the immune system, eliminating their ability to provide protection, according to an article to be published shortly in the Proceedings of the National Academy of Sciences (PNAS).

7 May 2009

New research nets the true economic costs of dengue fever

Researchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries.

7 May 2009